ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
"This is the first study to describe Emergency Physician's ability to [manage] both the procedural sedation and electrical cardioversion of class III and class IV obese patients," the authors wrote.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results